Laurus Labs receives US FDA inspection report

Laurus Labs Ltd today said it has received the establishment inspection report from the US Food and Drug Administration for its finished dosage formulations and active pharmaceutical ingredients manufacturing plant located in Achutapuram of Vishakhapatnam.

migrator

Published:15th Sep, 2017 at 10:21 PM

Hyderabad

In a regulatory filing the city-based drug maker said FDA inspected the unit in May.

The company further said the same unit had also completed the BGV Hamburg (German Regulatory Authority) inspection while the WHO successfully inspected the units 1 and 3 located at Parawada, Visakhapatnam during this month.

Laurus Labs' shares closed at Rs 549.80 almost flat on the Bombay Stock Exchange.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

Laurus Labs receives US FDA inspection report

Laurus Labs Ltd today said it has received the establishment inspection report from the US Food and Drug Administration for its finished dosage formulations and active pharmaceutical ingredients manufacturing plant located in Achutapuram of Vishakhapatnam.

Also Read

Chennai Ula Vintage bus service flagged off ahead of Pongal

Madhavaram and Manali lake boating facilities among Rs 39.78 crore civic works launched in North Chennai

Construction crane falls onto moving train in Thailand, killing at least 29 people

Fully booked flights leave travelers high and dry for Pongal

Bhogi celebrations shroud Chennai in smog, prompting health and visibility concerns